Lung Cancer

Rare EGFR mutations as oncogenic drivers

Presented By
Dr Alfredo Addeo (University Hospital of Geneva, Switzerland) and Dr Giulia Pasello (Veneto Institute of Oncology, Italy)
Conference
ELCC 2022

Thoracic cancers versus COVID-19

Presented By
Leora Horn, Vanderbilt-Ingram Cancer Center, USA
Trial
TERAVOLT
Conference
ASCO 2020

Combo I-O plus chemotherapy

Presented By
Dr Luis Paz-Ares, Complutense University of Madrid, Spain
Trial
Keynote-189, Impower-132
Conference
ELCC 2019

Brain irradiation as treatment option

Presented By
Prof. Corinne Faivre-Finn, The Christie NHS Foundation Trust and University of Manchester, UK
Trial
Phase 3, QUARTZ
Conference
ELCC 2019

Other I-O combinations

Presented By
Prof. Solange Peters, Lausanne University Hospital and Ludwig Institute, Switzerland
Trial
IMpower 150
Conference
ELCC 2019

Experiences from France

Presented By
Dr Benjamin Besse, Institut Gustave Roussy, France
Conference
ELCC 2019

Predictive diagnostics for I-O

Presented By
Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain
Trial
Phase 3, BFAST
Conference
ELCC 2019

Genomic and immune profiling

Presented By
Dr Ke-Zhong Chen, Peking University People’s Hospital, Beijing, China
Conference
ELCC 2019

Immunotherapy in SCLC: trial data

Presented By
Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain
Trial
CA184-156, CheckMate-451, CASPIAN, Keynote-604, Checkmate 032
Conference
ELCC 2019